{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:32:43Z","timestamp":1792168363092,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.metabol.2007.02.007","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T01:05:04Z","timestamp":1181783104000},"page":"939-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution"],"prefix":"10.1016","volume":"56","author":[{"given":"Steen B.","family":"Haugaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Halsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Nicholas","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2007.02.007_bib1","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2007.02.007_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.metabol.2007.02.007_bib3","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.2337\/diabetes.54.12.3474","article-title":"Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy","volume":"54","author":"Haugaard","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2007.02.007_bib4","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor\u2013associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2007.02.007_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2005.02223.x","article-title":"Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy","volume":"62","author":"Haugaard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2007.02.007_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/095632020501600106","article-title":"Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999-2003","volume":"16","author":"Bonnet","year":"2005","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.metabol.2007.02.007_bib7","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2007.02.007_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ajcn\/77.2.490","article-title":"Inhibition of lipolysis improves insulin sensitivity in protease inhibitor\u2013treated HIV-infected men with fat redistribution","volume":"77","author":"Hadigan","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2007.02.007_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.metabol.2005.08.018","article-title":"Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy","volume":"55","author":"Haugaard","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2007.02.007_bib10","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00056.2003","article-title":"Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy","volume":"286","author":"Johnson","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib11","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: lipodystrophy in human immunodeficiency virus\u2013infected patients","volume":"87","author":"Chen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2007.02.007_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2014association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2007.02.007_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2007.02.007_bib15","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1152\/ajpendo.00009.2004","article-title":"Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells","volume":"287","author":"Haugaard","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1293.2006.00364.x","article-title":"Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy","volume":"7","author":"Haugaard","year":"2006","journal-title":"HIV Med"},{"key":"10.1016\/j.metabol.2007.02.007_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2007.02.007_bib18","doi-asserted-by":"crossref","first-page":"E712","DOI":"10.1152\/ajpendo.2001.280.5.E712","article-title":"Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis","volume":"280","author":"Iozzo","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.02.007_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1079\/PNS2004349","article-title":"Metabolic flexibility","volume":"63","author":"Storlien","year":"2004","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.metabol.2007.02.007_bib21","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1152\/ajpendo.00274.2003","article-title":"Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue","volume":"286","author":"Krogh-Madsen","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2007.02.007_bib22","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/BF00400828","article-title":"Proinsulin processing in the regulated and the constitutive secretory pathway","volume":"37","author":"Halban","year":"1994","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2007.02.007_bib23","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1007\/BF00400840","article-title":"The pathogenesis of NIDDM","volume":"37","author":"Hales","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.02.007_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/diacare.22.2.262","article-title":"Fasting proinsulin concentrations predict the development of type 2 diabetes","volume":"22","author":"Wareham","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.02.007_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00125-002-0995-2","article-title":"Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men\u2014report from 27 years of follow-up study","volume":"46","author":"Zethelius","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.02.007_bib26","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/01.CIR.92.6.1422","article-title":"Insulin, intact and split proinsulin, and coronary artery disease in young men","volume":"92","author":"Bavenholm","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.02.007_bib27","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.CIR.0000015855.04844.E7","article-title":"Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study","volume":"105","author":"Zethelius","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.02.007_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj2600535","article-title":"Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins","volume":"260","author":"Sobey","year":"1989","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2007.02.007_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0169-2607(96)01755-5","article-title":"ISEC: a program to calculate insulin secretion","volume":"50","author":"Hovorka","year":"1996","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.metabol.2007.02.007_bib30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.02.007_bib31","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2007.02.007_bib32","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.51.4.937","article-title":"Indinavir induces acute and reversible peripheral insulin resistance in rats","volume":"51","author":"Hruz","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2007.02.007_bib33","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2007.02.007_bib34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/0003-4819-132-4-200002150-00024","article-title":"Protease inhibitors do not interfere with prohormone processing","volume":"132","author":"Danoff","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2007.02.007_bib35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/diab.38.11.1333","article-title":"Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?","volume":"38","author":"Porte","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2007.02.007_bib36","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jcem.82.6.3979","article-title":"Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals","volume":"82","author":"Jones","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/jcem-56-3-608","article-title":"Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels","volume":"56","author":"Rossell","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.metabol.2004.08.009","article-title":"In nondiabetic, human immunodeficiency virus\u2013infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance","volume":"54","author":"Haugaard","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2007.02.007_bib39","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s001250050945","article-title":"Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule","volume":"41","author":"Hovorka","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.02.007_bib40","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1210\/endo-127-5-2418","article-title":"Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites","volume":"127","author":"Tillil","year":"1990","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2007.02.007_bib41","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.2337\/diabetes.51.2007.S234","article-title":"Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans","volume":"51","author":"Fritsche","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2007.02.007_bib42","first-page":"192","article-title":"Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus","volume":"74","author":"Kahn","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF00296991","article-title":"Disproportionate elevation of immunoreactive proinsulin in type 2 (non\u2013insulin-dependent) diabetes mellitus and in experimental insulin resistance","volume":"30","author":"Ward","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.02.007_bib44","first-page":"44","article-title":"Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance","volume":"76","author":"Reaven","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib45","first-page":"604","article-title":"Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus","volume":"83","author":"Roder","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib46","first-page":"3221","article-title":"Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers","volume":"82","author":"Wang","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.02.007_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00400421","article-title":"Fasting proinsulin and 2h postload glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study","volume":"39","author":"Nijpels","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.02.007_bib48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2362.2006.01640.x","article-title":"Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients","volume":"36","author":"Haugaard","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2007.02.007_bib49","first-page":"S11","article-title":"Screening for type 2 diabetes (position statement)","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.02.007_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diabetes.54.1.166","article-title":"Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes","volume":"54","author":"Lyssenko","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2007.02.007_bib51","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.amjcard.2005.12.046","article-title":"Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUSTIMI 16 trial","volume":"97","author":"Bhadriraju","year":"2006","journal-title":"Am J Cardiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950700090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950700090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:19:51Z","timestamp":1758424791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604950700090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S002604950700090X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2007.02.007","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2007.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}